+49.2%
GSK vs OUST
-56.2%
+105.4%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | OUST | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | +1.7% | -3.6% | -1.9% |
| 7D | -1.8% | +5.2% | -7.1% | -1.9% |
| 30D | -2.2% | -19.3% | +17.1% | -2.1% |
| 3M | -1.8% | -22.6% | +20.8% | -1.9% |
| 6M | -10.6% | +62.8% | -73.4% | -11.5% |
| YTD | +4.4% | +68.3% | -63.9% | +3.3% |
| 1Y | +30.4% | +28.5% | +1.9% | +29.2% |
| 3Y | +60.1% | +554.0% | -494.0% | +53.6% |
| All | +49.2% | -56.2% | +105.4% | +45.1% |
Cumulative growth
Daily Returns
Daily percentage return beside OUST.
Daily Out/Under-Performance
Portfolio return minus OUST return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × OUST return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded OUST wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling